USP7 is known to regulate drug resistance by stabilizing its targets, which include a range of oncogenes and tumor suppressors (Chauhan et al., 2012; Song et al., 2008), NEK2 is one of the USP7 targets. This evidence concerns the gene NEK2 and neoplasm.